Jul 30, 2023, 06:39
This is another milestone for peptomyc and its fantastic team – Laura Soucek
We are thrilled to announce that we finally have the approval for our Phase 1b study to test OMO-103 in metastatic PDAC patients in combination with standard of care in first line! This is another milestone for peptomyc and its fantastic team. Stay tuned.
Source: Laura Soucek/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 16:21
Jan 15, 2025, 16:20
Jan 15, 2025, 16:16
Jan 15, 2025, 16:13
Jan 15, 2025, 16:11
Jan 15, 2025, 15:57
Jan 15, 2025, 15:20